Immune Checkpoint Inhibitor Myocarditis and Left Ventricular Systolic Dysfunction
Yen-Chou Chen, Charles Dolladille, Anjali Rao, Nicolas L. Palaskas, Anita Deswal, Lorenz Lehmann, Jennifer Cautela, Pierre‐Yves Courand, Salim S. Hayek, Han Zhu, Richard K. Cheng, Joachim Alexandre, Lauren A. Baldassarre, François Roubille, Michal Laufer‐Perl, Aarti Asnani, Stephane Ederhy, Yuichi Tamura, Sanjeev Francis, Elizabeth M Gaughan, Douglas B. Johnson, Danette L. Flint, Peter P. Rainer, Guillaume Bailly, Steven M. Ewer, Mandar A. Aras, Dimitri Arangalage, Eve Cariou, Roberta Florido, Giovanni Peretto, Osnat Itzhaki Ben Zadok, Nausheen Akhter, Anna Narezkina, Joshua Levenson, Yan Liu, Shanthini M. Crusz, N. Issa, Nicolas Piriou, Darryl P. Leong, Shahneen Sandhu, Isik Turker, Pedro Moliner, Michel Obéid, Lucie Heinzerling, Wei‐Ting Chang, Andrew Stewart, Vishnu Venkatesh, Z Y Du, Anirudh Yadavalli, Do‐Hyeong Kim, Alvin Chandra, Kathleen W. Zhang, John R. Power, Javid J. Moslehi, Joe‐Elie Salem, Vlad G. Zaha (2025). Immune Checkpoint Inhibitor Myocarditis and Left Ventricular Systolic Dysfunction. , 7(3), DOI: https://doi.org/10.1016/j.jaccao.2025.01.020.
